BSE:M has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BSE:M has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Med Life SA BSE:M
Med Life BSE:M 91 Enterprise Value is lei7,976 Mil as of Jun. 30, 2026. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.82 (Significantly Overvalued). The stock has 4 warning signs investors should review.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was lei83 Mil. Therefore, Med Life's EV-to-EBIT ratio for today is 96.25.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was lei307 Mil. Therefore, Med Life's EV-to-EBITDA ratio for today is 26.00.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was lei2,437 Mil. Therefore, Med Life's EV-to-Revenue ratio for today is 3.27.
EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was lei154 Mil. Therefore, Med Life's EV-to-OCF ratio for today is 51.83.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was lei9 Mil. Therefore, Med Life's EV-to-FCF ratio for today is 906.24.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Med Life (BSE:M) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Med Life's EV-to-EBIT for today is
| EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
| = | 7975.820 | / | 82.866 | |
| = | 96.25 |
Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei83 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Med Life's EV-to-EBITDA for today is:
| EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
| = | 7975.820 | / | 306.733 | |
| = | 26.00 |
Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei307 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
Med Life's EV-to-Revenue for today is:
| EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
| = | 7975.820 | / | 2437.423 | |
| = | 3.27 |
Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei2,437 Mil.
4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.
Med Life's EV-to-OCF for today is:
| EV-to-OCF | = | Enterprise Value (Today) | / | Cash Flow from Operations (TTM) |
| = | 7975.820 | / | 153.871 | |
| = | 51.83 |
Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei154 Mil.
5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.
Med Life's EV-to-FCF for today is:
| EV-to-FCF | = | Enterprise Value (Today) | / | Free Cash Flow (TTM) |
| = | 7975.820 | / | 8.801 | |
| = | 906.24 |
Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The historical data trend for Med Life's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Med Life Annual Data | |||||||||||||||||||||
| Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
| Enterprise Value | Get a 7-Day Free Trial |
|
|
2,052.01 | 3,685.63 | 3,322.77 | 3,634.72 | 4,793.23 | |||||||||||||
| Med Life Quarterly Data | ||||||||||||||||||||
| Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Mar26 | |
| Enterprise Value | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
4,793.23 | 5,141.04 | 5,362.90 | 5,985.49 | 8,156.30 | ||
For the Medical Care Facilities subindustry, Med Life's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Med Life's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Med Life's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
| Enterprise Value (A: Dec. 2024 ) | |||||
| = | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
| = | 3080.177 | + | 0 | + | 1488.195 |
| + | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
| + | 263.667 | + | 74.159 | - | 112.972 |
| = | 4,793 |
Med Life's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as
| Enterprise Value (Q: Mar. 2026 ) | |||||
| = | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
| = | 6231.77984 | + | 0 | + | 1781.626 |
| + | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
| + | 237.75 | + | 73.553 | - | 168.411 |
| = | 8,156 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.40 is trading 45.8% above its estimated GF Value™ of lei7.82. GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.